Device Week, Nov. 19, 2021 – J&J Break Up And Genomic Diagnostics

In this edition of Device Week, Medtech Insight’s Reed Miller chats to Marion Webb about the recent announcement that Johnson & Johnson will split into two separate businesses – one focusing on medical products, and the other focusing on consumer. Reed and Barnaby also discuss recent results from the UK’s 100,000 Genome project, and how its analysis partner, Congenica, hopes to deliver personalized medicine through widescale genomic testing Medtech Insight articles addressing topics discussed in this episode: J&J To Split Consumer From Medtech and Pharmaceutical Businesses – Creating Two Companies To Unlock More Value, Growth, Innovation - https://medtech.pharmaintelligence.informa.com/MT144717/JJ-To-Split-Consumer-From-Medtech-and-Pharmaceutical-Businesses--Creating-Two-Companies-To-Unlock-More-Value-Growth-Innovation - Congenica Tries To Bring Clarity To Personalized Medicine For Rare Diseases -https://medtech.pharmaintelligence.informa.com/MT144723/Congenica-Tries-To-Bring-Clarity-To-Personalized-Medicine-For-Rare-Diseases